Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protection of coronary microcirculation by iloprost during PCI
2008-001319-39Phase 4Terminated
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of iloprost in coronary arteriosclerosis, acute coronary syndrome (ACS) and Non-ST-segment elevation myocardial infarction (NSTEMI), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Peri-procedural myocardial infarction by troponin elevation. Started Jul 2008; status: terminated.
02
Drugs
iloprost
03
Conditions
coronary arteriosclerosisacute coronary syndrome (ACS)Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2008-001319-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001319-39.